Rockwell Medical, Inc. logo

Rockwell Medical, Inc.

NASDAQ:RMTI

Overview | Financials
Company Name Rockwell Medical, Inc.
Symbol RMTI
Currency USD
Price 1.01
Market Cap 34,516,447
Dividend Yield 0%
52-week-range 0.86 - 5.15
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Mark Strobeck Ph.D.
Website https://www.rockwellmed.com

An error occurred while fetching data.

About Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy

Related Stocks

Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc.

UNCY

0.763 USD

Star Equity Holdings, Inc. logo

Star Equity Holdings, Inc.

STRR

2.2 USD

Financials

Numbers are in millions USD

Numbers are in millions USD